Sanjay Gupta
Oncology · 2008–2011
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 15 citations into it
- Biochemistry — 8 citations into it
- Molecular Biology — 7 citations into it
Whom Sanjay Gupta trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Sanjay Gupta's perspective
Ordered by how strongly the researchers Sanjay Gupta trusts endorse each paper. Same corpus, a different order for every researcher.
- A 5‐decade analysis of 13,715 carcinoid tumors (Cancer)
- Erlotinib in previously treated non-small-cell lung cancer. (New England Journal of Medicine)
- The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. (Pharmacological Reviews)
- Modelling the molecular circuitry of cancer (Nature Reviews. Cancer)
- TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system (Virchows Archiv)
- Inhibition of carcinogenesis by dietary polyphenolic compounds. (Annual review of nutrition)
- Flavonoids: antioxidants or signalling molecules? (Free Radical Biology & Medicine)
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. (The Lancet)
- Gene silencing in mammals by small interfering RNAs (Nature reviews genetics)
- Links between innate and adaptive immunity via type I interferon. (Current Opinion in Immunology)
Their papers
- The BATTLE Trial: Personalizing Therapy for Lung Cancer (2011) — 859 citations
- Apigenin: A Promising Molecule for Cancer Prevention (2010) — 785 citations
- Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. (2008) — 634 citations